Skip to Content

Watson 372 50 mg (Loxapine Succinate 50 mg)

Pill with imprint Watson 372 50 mg is Blue & White, Capsule-shape and has been identified as Loxapine Succinate 50 mg. It is supplied by Watson Laboratories, Inc..

Loxapine is used in the treatment of agitated state; agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 372 50 mg

Loxapine succinate 50 mg Watson 372 50 mg
Loxapine succinate 50 mg Watson 372 50 mg
Loxapine succinate 50 mg Watson 372 50 mg
Loxapine succinate 50 mg Watson 372 50 mg

Loxapine Succinate

Imprint
Watson 372 50 mg
Strength
50 mg
Color
Blue & White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antipsychotic agents
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
lactose anhydrous, benzyl alcohol, butylparaben, edetate calcium disodium, gelatin, magnesium stearate, methylparaben, polacrilin potassium, propylparaben, sodium lauryl sulfate, sodium propionate, magnesium silicate, titanium dioxide, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-0372 Watson Pharmaceuticals, Inc.
51079-0903 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "Watson 372 50 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.